Human Fibrinogen Concentrates Market Size to Hit USD 2.50 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Human Fibrinogen Concentrates Market

5.1. COVID-19 Landscape: Human Fibrinogen Concentrates Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Human Fibrinogen Concentrates Market, By Type

8.1. Human Fibrinogen Concentrates Market Revenue and Volume Forecast, by Type

8.1.1. Plasma-Derived Fibrinogen Concentrates

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Recombinant Fibrinogen Concentrates

8.1.2.1. Market Revenue and Volume Forecast

Chapter 9. Global Human Fibrinogen Concentrates Market, By Application

9.1. Human Fibrinogen Concentrates Market Revenue and Volume Forecast, by Application

9.1.1. Congenital Fibrinogen Deficiency

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Acquired Fibrinogen Deficiency

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Surgical Bleeding

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Trauma

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Obstetric Bleeding

9.1.5.1. Market Revenue and Volume Forecast

Chapter 10. Global Human Fibrinogen Concentrates Market, By End-User

10.1. Human Fibrinogen Concentrates Market Revenue and Volume Forecast, by End-User

10.1.1. Hospitals

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Specialty Clinics

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Ambulatory Surgical Centers

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Research & Academic Institutes

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global Human Fibrinogen Concentrates Market, By Distribution Channel

11.1. Human Fibrinogen Concentrates Market Revenue and Volume Forecast, by Distribution Channel

11.1.1. Hospital Pharmacies

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Retail Pharmacies

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Online Pharmacies

11.1.3.1. Market Revenue and Volume Forecast

Chapter 12. Global Human Fibrinogen Concentrates Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Type

12.1.2. Market Revenue and Volume Forecast, by Application

12.1.3. Market Revenue and Volume Forecast, by End-User

12.1.4. Market Revenue and Volume Forecast, by Distribution Channel

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Type

12.1.5.2. Market Revenue and Volume Forecast, by Application

12.1.5.3. Market Revenue and Volume Forecast, by End-User

12.1.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Type

12.1.6.2. Market Revenue and Volume Forecast, by Application

12.1.6.3. Market Revenue and Volume Forecast, by End-User

12.1.6.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Type

12.2.2. Market Revenue and Volume Forecast, by Application

12.2.3. Market Revenue and Volume Forecast, by End-User

12.2.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Type

12.2.5.2. Market Revenue and Volume Forecast, by Application

12.2.5.3. Market Revenue and Volume Forecast, by End-User

12.2.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Type

12.2.6.2. Market Revenue and Volume Forecast, by Application

12.2.6.3. Market Revenue and Volume Forecast, by End-User

12.2.6.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Type

12.2.7.2. Market Revenue and Volume Forecast, by Application

12.2.7.3. Market Revenue and Volume Forecast, by End-User

12.2.7.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Type

12.2.8.2. Market Revenue and Volume Forecast, by Application

12.2.8.3. Market Revenue and Volume Forecast, by End-User

12.2.8.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Type

12.3.2. Market Revenue and Volume Forecast, by Application

12.3.3. Market Revenue and Volume Forecast, by End-User

12.3.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Type

12.3.5.2. Market Revenue and Volume Forecast, by Application

12.3.5.3. Market Revenue and Volume Forecast, by End-User

12.3.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Type

12.3.6.2. Market Revenue and Volume Forecast, by Application

12.3.6.3. Market Revenue and Volume Forecast, by End-User

12.3.6.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Type

12.3.7.2. Market Revenue and Volume Forecast, by Application

12.3.7.3. Market Revenue and Volume Forecast, by End-User

12.3.7.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Type

12.3.8.2. Market Revenue and Volume Forecast, by Application

12.3.8.3. Market Revenue and Volume Forecast, by End-User

12.3.8.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Type

12.4.2. Market Revenue and Volume Forecast, by Application

12.4.3. Market Revenue and Volume Forecast, by End-User

12.4.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Type

12.4.5.2. Market Revenue and Volume Forecast, by Application

12.4.5.3. Market Revenue and Volume Forecast, by End-User

12.4.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Type

12.4.6.2. Market Revenue and Volume Forecast, by Application

12.4.6.3. Market Revenue and Volume Forecast, by End-User

12.4.6.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Type

12.4.7.2. Market Revenue and Volume Forecast, by Application

12.4.7.3. Market Revenue and Volume Forecast, by End-User

12.4.7.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Type

12.4.8.2. Market Revenue and Volume Forecast, by Application

12.4.8.3. Market Revenue and Volume Forecast, by End-User

12.4.8.4. Market Revenue and Volume Forecast, by Distribution Channel

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Type

12.5.2. Market Revenue and Volume Forecast, by Application

12.5.3. Market Revenue and Volume Forecast, by End-User

12.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Type

12.5.5.2. Market Revenue and Volume Forecast, by Application

12.5.5.3. Market Revenue and Volume Forecast, by End-User

12.5.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Type

12.5.6.2. Market Revenue and Volume Forecast, by Application

12.5.6.3. Market Revenue and Volume Forecast, by End-User

12.5.6.4. Market Revenue and Volume Forecast, by Distribution Channel

Chapter 13. Company Profiles

13.1. CSL Behring

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial PerTypeance

13.1.4. Recent Initiatives

13.2. Octapharma AG

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial PerTypeance

13.2.4. Recent Initiatives

13.3. LFB Group

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial PerTypeance

13.3.4. Recent Initiatives

13.4. Grifols, S.A.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial PerTypeance

13.4.4. Recent Initiatives

13.5. Shanghai RAAS Blood Products Co., Ltd.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial PerTypeance

13.5.4. Recent Initiatives

13.6. Baxter International

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial PerTypeance

13.6.4. Recent Initiatives

13.7. Hualan Biological Engineering Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial PerTypeance

13.7.4. Recent Initiatives

13.8. Jiangxi Boya Bio Pharmaceutical

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial PerTypeance

13.8.4. Recent Initiatives

13.9. Green Cross Corporation

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial PerTypeance

13.9.4. Recent Initiatives

13.10. Harbin Pacific Biopharmaceutical Co., Ltd.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerTypeance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The human fibrinogen concentrates market size is expected to increase from USD 1.33 billion in 2025 to USD 2.50 billion by 2034.

The human fibrinogen concentrates market is expected to grow at a compound annual growth rate (CAGR) of around 7.26% from 2025 to 2034.

The major players in the human fibrinogen concentrates market include Harbin Pacific Biopharmaceutical Co., Ltd., Green Cross Corporation, Jiangxi Boya Bio Pharmaceutical, Hualan Biological Engineering Inc., Shanghai RAAS Blood Products Co., Ltd. and Grifols, S.A.

The driving factors of the human fibrinogen concentrates market are the increased numbers of surgical procedures and prevalence of bleeding disorders are driving the growth of the human fibrinogen concentrates market.

North America region will lead the global human fibrinogen concentrates market during the forecast period 2025 to 2034.